Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	32.35	9.7	0.46	16.58	-	0.02
Cash & Short-Term Investments	32.35	9.7	0.46	16.58	-	0.02
Cash Growth	125.49%	2032.09%	-97.26%	-	-	-40.00%
Prepaid Expenses	4.71	3.37	2.03	1.71	-	0
Other Current Assets	0.69	0.33	0.16	0.13	0.2	-
Total Current Assets	37.74	13.4	2.64	18.41	0.2	0.02
Property, Plant & Equipment	0.83	0.79	0.17	0.33	-	-
Total Assets	38.57	14.19	2.82	18.74	0.2	0.02
Accounts Payable	0.55	0.84	0.89	0.74	0.18	0.32
Accrued Expenses	2.99	3.23	2.24	1.21	0.18	0.12
Short-Term Debt	-	-	-	-	2.51	0.46
Current Portion of Leases	0.54	0.33	0.16	0.15	-	-
Other Current Liabilities	6.38	13.13	-	-	-	-
Total Current Liabilities	10.46	17.53	3.28	2.11	2.88	0.9
Long-Term Leases	0.27	0.47	-	0.16	-	-
Total Liabilities	10.72	18	3.28	2.26	2.88	0.9
Common Stock	0.1	0.04	0.02	0.02	0.01	0.04
Additional Paid-In Capital	107.5	60.7	33.52	32.41	3.24	2.74
Retained Earnings	-79.75	-64.54	-34	-15.94	-5.92	-3.66
Shareholders' Equity	27.85	-3.81	-0.47	16.48	-2.67	-0.88
Total Liabilities & Equity	38.57	14.19	2.82	18.74	0.2	0.02
Total Debt	0.81	0.79	0.16	0.31	2.51	0.46
Net Cash (Debt)	31.54	8.91	0.3	16.27	-2.51	-0.45
Net Cash Growth	133.99%	2869.33%	-98.16%	-	-	-
Net Cash Per Share	0.64	0.36	0.02	1.39	-0.30	-0.05
Filing Date Shares Outstanding	103.8	34.76	15.23	15	8.9	8.46
Total Common Shares Outstanding	97.86	34.76	15.23	15	8.51	8.46
Working Capital	27.28	-4.14	-0.64	16.31	-2.67	-0.88
Book Value Per Share	0.28	-0.11	-0.03	1.10	-0.31	-0.10
Tangible Book Value	27.85	-3.81	-0.47	16.48	-2.67	-0.88
Tangible Book Value Per Share	0.28	-0.11	-0.03	1.10	-0.31	-0.10
Machinery	0.06	0.02	0.01	0.01	-	-
Leasehold Improvements	0.04	0.02	0.02	0.02	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.